Lv4
520 积分 2020-05-24 加入
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
3小时前
已完结
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
3小时前
已关闭
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
4小时前
已完结
Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM
2个月前
已完结
A Review of Clinical and Imaging Features of Diffuse Pulmonary Hemorrhage
4个月前
已完结
Diagnosis and management of ANCA-associated vasculitis
6个月前
已完结
Interstitial lung diseases
6个月前
已完结
Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM
9个月前
已完结
[Chinese expert consensus on treatment of malignant pleural effusion (2023 Edition)]
11个月前
已完结
Considering biomarkers in asthma disease severity
1年前
已完结
皖公网安备34019202002308
